19 diseases, which Evo Series can I review? EvoStem · EvoNK · Evo Mix & Hybrid Application review items according to disease characteristics
We do not decide on a program based solely on the name of the disease. A review of the Evo Series begins with an accurate diagnosis and standard treatment.
1. Cause and progression stage of the disease 2. Current treatment process and response 3. Test results and underlying disease 4. Patient’s general condition ※ The above items are combined to determine the direction of individual review.
EvoStem Review Group — Brain, Nerve, and Senses Application Review Items in the Brain, Nerve, and Sensory Areas
1. Dementia 2. Stroke 3. Parkinson’s disease 4. Cerebellar atrophy 5. Macular degeneration 6. ALS·Lou Gehrig’s disease
※ The extent of nerve damage, degree of functional decline, existing treatment, and rehabilitation progress are also checked. ALS and Lou Gehrig's disease are categorized into research review items and examined carefully.
EvoStem Review Group — Musculoskeletal/Respiratory Application Review Items in Musculoskeletal/Respiratory Areas
1. Arthritis 2. Muscular dystrophy 3. COPD/emphysema
※ The direction of review may vary depending on the degree of damage to joints and muscles, respiratory function, and currently ongoing drug treatment and rehabilitation process.
EvoStem review group — Metabolism, blood vessels, and organs Application review items in the areas of metabolism, blood vessels, and organs
1. Diabetes 2. Cardiovascular disease 3. Kidney disease 4. Diabetic complications 5. Sexual dysfunction
※ After checking blood sugar and blood pressure management, organ function, and the type and progress of complications, we look at the possibility of auxiliary and research review.
EvoNK Review Group Application Review Items in Cancer and Immunity Areas
- cancer
※ First, check the type and stage of cancer, genetic test results, standard treatment plan and progress including surgery, anticancer, radiation, targeted, and immunotherapy. Afterwards, an individual review is conducted based on the patient's immune and systemic conditions.
Evo Mix & Hybrid Review Group A composite review item that looks at both regeneration and immunity.
1. IgA nephropathy 2. Multiple sclerosis 3. Pulmonary fibrosis 4. Rheumatoid arthritis
※ We will focus on diseases that involve a combination of immune abnormalities, inflammation, tissue damage, or fibrosis. Pulmonary fibrosis can be considered as a candidate for EvoStem or Hybrid, depending on the patient's condition.
Conclusion/next episode preview The review group is not a classification that confirms the possibility of treatment.
Even for the same disease, review results may vary depending on the cause, stage of progression, response to existing treatment, and systemic condition. Actual application is determined through diagnosis and individual evaluation by medical staff.
How are EvoStem · EvoNK · Evo Mix & Hybrid different?
LACELLIC Clinic 6th and 7th floors, 503 Bongeunsa-ro, Gangnam-gu, Seoul 71-9 Samseong-dong, Gangnam-gu, Seoul
Inquiry +82 10-7667-6057
LACELLIC Clinic 6th and 7th floors, 503 Bongeunsa-ro, Gangnam-gu, Seoul
